Newer drugs in the treatment of peptic ulcer.
D000535:Aluminum / Q000494:pharmacology / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000494:pharmacology / Q000627:therapeutic use; D001729:Bismuth / Q000494:pharmacology / Q000627:therapeutic use; D002927:Cimetidine / Q000494:pharmacology / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D009853:Omeprazole; D009942:Organometallic Compounds; D010437:Peptic Ulcer / Q000188:drug therapy*; D010890:Pirenzepine; D011453:Prostaglandins / Q000494:pharmacology / Q000627:therapeutic use; D011899:Ranitidine / Q000494:pharmacology / Q000627:therapeutic use; D013392:Sucralfate
D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D001570:Benzodiazepinones; D009942:Organometallic Compounds; D011453:Prostaglandins; D010890:Pirenzepine; D013392:Sucralfate; D002927:Cimetidine; D011899:Ranitidine; D000535:Aluminum; C002791:bismuth tripotassium dicitrate; D009853:Omeprazole; D001729:Bismuth